The estimated Net Worth of Stephen Manzano is at least $138 mil dollars as of 27 February 2021. Mr Manzano owns over 16,490 units of Amneal Pharmaceuticals Inc stock worth over $137,856 and over the last 5 years he sold AMRX stock worth over $0.
Mr has made over 1 trades of the Amneal Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he exercised 16,490 units of AMRX stock worth $137,856 on 27 February 2021.
The largest trade he's ever made was exercising 16,490 units of Amneal Pharmaceuticals Inc stock on 27 February 2021 worth over $137,856. On average, Mr trades about 5,497 units every 0 days since 2020. As of 27 February 2021 he still owns at least 16,490 units of Amneal Pharmaceuticals Inc stock.
You can see the complete history of Mr Manzano stock trades at the bottom of the page.
Stephen J. Manzano is the Sr. VP, Gen. Counsel & Corp. Sec. at Amneal Pharmaceuticals Inc.
Mr Manzano is 56, he's been the Sr. VP e Gen. Counsel & Corp. Sec. of Amneal Pharmaceuticals Inc since . There are 5 older and 17 younger executives at Amneal Pharmaceuticals Inc. The oldest executive at Amneal Pharmaceuticals Inc is Shlomo Yanai, 67, who is the Independent Director.
Stephen's mailing address filed with the SEC is C/O AMNEAL PHARMACEUTICALS, INC., 400 CROSSING BOULEVARD, BRIDGEWATER, NJ, .
Over the last 7 years, insiders at Amneal Pharmaceuticals Inc have traded over $867,197,480 worth of Amneal Pharmaceuticals Inc stock and bought 3,818,425 units worth $12,997,905 . The most active insiders traders include Gp A, Llcbonderman Davidcou..., Holdings, Llc Aphc, eInternational Ltd Fosun. On average, Amneal Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of $3,857,739. The most recent stock trade was executed by Andrew S Boyer on 14 August 2024, trading 62,711 units of AMRX stock currently worth $491,654.
an american pharmaceutical company, amneal develops and produces affordable medicines. the company was built upon a family tradition of quality and integrity. everything amneal does, across the full spectrum of its business, is in service to these guiding principles. amneal is committed to constantly elevating and refining the value it delivers to its customers and patients around the globe.
Amneal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: